SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Amgen Inc. (AMGN) trades at a trailing P/E of 24.5, forward P/E of 15.7. Trailing earnings yield is 4.07%, forward earnings yield 6.39%. PEG 0.28 (Peter Lynch undervalued ≤1.0). Graham Number is $71.91.
Criteria proven by this page:
- VALUE (33/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 15.7 (down from trailing 24.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.28 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.07% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 6.39% as earnings recover.
- Analyst consensus target $347.73 (-0.9% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 64/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
33/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AMGN
Valuation Multiples
P/E (TTM)24.5
Forward P/E15.7
PEG Ratio0.28
Forward PEG0.27
P/B Ratio21.86
P/S Ratio5.15
EV/EBITDA12.6
Per Share Data
EPS (TTM)$14.31
Forward EPS (Est.)$22.41
Book Value / Share$16.06
Revenue / Share$68.22
FCF / Share$15.03
Yields & Fair Value
Earnings Yield4.07%
Forward Earnings Yield6.39%
Dividend Yield2.75%
Graham Number$71.91
SharesGrow IV$457.46 (+30.3%)
Analyst Target$347.73 (-0.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
14.2 |
1.11 |
3.66 |
4.76 |
2.74% |
| 2017 |
64.2 |
-0.87 |
5.04 |
5.56 |
2.65% |
| 2018 |
15.3 |
0.04 |
10.29 |
5.42 |
2.73% |
| 2019 |
18.6 |
9.08 |
15.08 |
6.24 |
2.41% |
| 2020 |
18.5 |
-4.29 |
14.32 |
5.30 |
2.79% |
| 2021 |
21.8 |
-1.31 |
19.14 |
4.94 |
3.13% |
| 2022 |
21.6 |
1.21 |
38.60 |
5.37 |
2.97% |
| 2023 |
22.9 |
7.35 |
24.73 |
5.47 |
2.96% |
| 2024 |
34.5 |
-0.88 |
23.99 |
4.22 |
3.43% |
| 2025 |
22.8 |
0.26 |
20.34 |
4.79 |
2.91% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$10.24 |
$22.99B |
$7.72B |
33.6% |
| 2017 |
$2.69 |
$22.85B |
$1.98B |
8.7% |
| 2018 |
$12.62 |
$23.75B |
$8.39B |
35.3% |
| 2019 |
$12.88 |
$23.36B |
$7.84B |
33.6% |
| 2020 |
$12.31 |
$25.42B |
$7.26B |
28.6% |
| 2021 |
$10.28 |
$25.98B |
$5.89B |
22.7% |
| 2022 |
$12.11 |
$26.32B |
$6.55B |
24.9% |
| 2023 |
$12.49 |
$28.19B |
$6.72B |
23.8% |
| 2024 |
$7.56 |
$33.42B |
$4.09B |
12.2% |
| 2025 |
$14.23 |
$36.74B |
$7.71B |
21% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$22.41 |
$20.70 – $23.57 |
$37.84B |
$37.46B – $38.67B |
21 |
| 2027 |
$23.35 |
$21.45 – $24.83 |
$38.87B |
$37.31B – $40.09B |
19 |
| 2028 |
$24.22 |
$18.95 – $32.36 |
$39.77B |
$39.77B – $39.77B |
10 |
| 2029 |
$25.50 |
$24.60 – $26.91 |
$41.4B |
$40.28B – $43.17B |
4 |
| 2030 |
$27.55 |
$26.58 – $29.08 |
$42.75B |
$41.59B – $44.58B |
4 |
